Cardiomyopathies and myocardial disorders in Africa: Present status and the way forward

Cardiovascular Journal of Africa

Volumn 23, Issue 10, 2012, Pages 552-562

  Falase, Ayodele O ^a   Ogah, Okechukwu S ^a  

^a UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

Africa; Cardiomyopathy; Sub Saharan Africa

Indexed keywords

AFRICA; ALCOHOL CONSUMPTION; ARTICLE; BRUGADA SYNDROME; CARDIOMYOPATHY; CARDIOVASCULAR MORTALITY; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; CHANNELOPATHY; CONGENITAL HEART DISEASE; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; DISEASE CLASSIFICATION; GENETIC DISORDER; HEART DISEASE; HEART FAILURE; HEART HEMOSIDEROSIS; HEART LEFT VENTRICLE ANEURYSM; HEART MUSCLE FIBROSIS; HEART MUSCLE INJURY; HEART RIGHT VENTRICLE DYSPLASIA; HEART VENTRICLE FIBRILLATION; HUMAN; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; ISCHEMIC CARDIOMYOPATHY; ISCHEMIC HEART DISEASE; LONG QT SYNDROME; MALNUTRITION; MORBIDITY; MYOCARDIAL DISEASE; MYOCARDITIS; PERIPARTUM CARDIOMYOPATHY; POTASSIUM DEFICIENCY; PREVALENCE; PROGRESSIVE CARDIAC CONDUCTION DEFECT; PULMONARY VALVE INSUFFICIENCY; RESTRICTIVE CARDIOMYOPATHY; SHORT QT SYNDROME; VENTRICULAR NONCOMPACTION;

AFRICA; ANIMALS; CARDIOMYOPATHIES; HUMANS; HYPERTENSION; MYOCARDIUM;

EID: 84874060786     PISSN: 19951892     EISSN: None     Source Type: Journal    
DOI: 10.5830/CVJA-2012-046     Document Type: Article

References (88)

1. Carlisle R, Ogunlesi TO. Prospective study of adult cases presenting at the Cardiac Unit, University College Hospital, Ibadan 1968 and 1969. Afr J Med Sci 1972; 3: 13-25.
2. Mayosi BM. Contemporary trends in the epidemiology and management of cardiomyopathy and pericarditis in sub-Saharan Africa. Heart 2007; 93: 1176-1183.
3. Ogah OS, Adegbite GD, Akinyemi OO, et al. Epidemiology of Acute Heart Failure in Southern Nigeria: Data From The Abeokuta Heart Failure Registry (Abstract). Circulation 2010; 122: e116.
4. Reesinger JA, Blumenthal B. Myocardial degeneration with hypertrophy and failure of unknown case. Am Heart J 1941; 22: 811-824.
5. Gillanders AD. Nutritional heart disease. Br Heart J 1951; 13: 177-196.
6. Becker BJP, Chatgidakis CBBVL. Cardiovascular collagenosis with parietal endocardial thrombosis. Circulation 1953; 7: 345-356.
7. Brigden W. Uncommon myocardial disease: The non-coronary cardiomyopathies. Lancet 1957; 2:1179.
8. Cardiomyopathies. Bull Wld Hlth Org 1965; 33: 257-266.
9. Teare D. Asymmetrical hypertrophy of the heart in young adults. Br Heart J 1958; 20: 1-8.
10. Cardiomyopathies. Technical Report Series: World Health Organisation (WHO) 1984; 697.
11. Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies. Br Heart J 1980; 44: 672-673.
12. Bedford DE, Konstam GLS. Heart failure of unknown origin in Africans. Br Heart J 1946; 8:236.
13. Löffler W. Endocarditis parietalis fibroplastica mit Bluteosinophilie. Schweiz med Wchnshr 1936; 66:817.
14. Andy JJ, Bishara FF, Soyinka OO. Relation of severe eosinophilia and microfilariasis to chronic African endomyocardial fibrosis. Br Heart J 1981; 45: 672-680.
15. Oakley C. Diagnosis and natural history of congested (dilated) cardiomyopathies. Postgrad Med J 1978; 54: 440-450.
16. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 1996; 93: 841-842.
17. Maron BJ, Towbin JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 2006; 113: 1807-1816.
18. Maro EE, Janabi M, Kaushik R. Clinical and echocardiographic study of hypertrophic cardiomyopathy in Tanzania. Trop Doct 2006; 36: 225-227.
19. Mbakwem A, Oke D, Ajuluchukwu J. Hypertrophic cardiomyopathy in South Western Nigeria. S Afr Heart J 2009; 6: 4-109.
20. Sliwa K, Damasceno A, Mayosi BM. Epidemiology and etiology of cardiomyopathy in Africa. Circulation 2005; 112: 3577-3583.
21. Amoah AG, Kallen C. Aetiology of heart failure as seen from a National Cardiac Referral Centre in Africa. Cardiology 2000; 93: 11-18.
22. Abegaz B. The impact of echocardiography in the diagnosis of hypertrophic cardiomyopathy. East Afr Med J 1990; 67: 556-567.
23. Mbakwem A, Oke DA, Ajuluchukwu J. Hypertrophic cardiomyopathy in South Western Nigeria. S Afr Heart J 2009; 6: 104-109.
24. Heradien M, Goosen A, Moolman-Smook JC, Brink PA. Race and gender representation of hypertrophic cardiomyopathy or long QT syndrome cases in a South African research setting. Cardiovasc J Afr 2007; 18: 312-315.
25. Mokhobo KP, Mntla PS. Lone ventricular cardiomyopathy, 1993-1996. S Afr Med J 1997; 87: 892-896.
26. Brockington IF, Edington GM, Olsen EG. Nigerian 'heart muscle disease': the late stages of untreated hypertensive heart failure? Acta Cardiol 1977; 32: 245-267.
27. Powell SJ, Wright R. Cardiomyopathy in Durban. S Afr Med J 1965; 39: 1062-1066.
28. Falase AO. Cardiomegaly of unknown origin among Nigerian adults: role of hypertension in its aetiology. Br Heart J 1977; 39: 671-679.
29. Falase AO. Heart muscle disease among adult Nigerians: role of nutritional factors in its aetiology. Eur J Cardiol 1979; 10: 197-204.
30. Falase AO, Fabiyi A, Ogunba EO. Heart muscle disease in Nigerian adults: a multifactorial disease. Afr J Med Med Sci 1977; 6: 165-176.
31. Falase AO. Infections and dilated cardiomyopathy in Nigeria. Heart Vessels (Suppl) 1985; 1: 40-44.
32. Falase AO, Fabiyi A, Odegbo-Olukoya OO. Coxsackie B viruses and heart muscle disease in Nigerian adults. Trop Geogr Med 1979; 31: 237-243.
33. Falase AO, Sekoni GA, Adenle AD. Dilated cardiomyopathy in young adult Africans: a sequel to infections? Afr J Med Med Sci 1982; 11: 1-5.
34. Aje A, Adebiyi AA, Falase AO. Hypertensive heart disease in Africa. S Afr Heart J 2009; 6: 42-51.
35. Falase AO, Ayeni O, Sekoni GA, Odia OJ. Heart failure in Nigerian hypertensives. Afr J Med Med Sci 1983; 12: 7-15.
36. Rees RH, Rees MC, Fulton WF, Gichinga M. Cardiomyopathy in Nairobi - a follow-up study. East Afr Med J 1974; 51: 863-868.
37. Sanderson JE, Olsen EG, Gatei D. Peripartum heart disease: an endomyocardial biopsy study. Br Heart J 1986; 56: 285-291.
38. Sanderson JE, Olsen EG, Gatei D. Dilated cardiomyopathy and myocarditis in Kenya: an endomyocardial biopsy study. Int J Cardiol 1993; 41: 157-163.
39. Shaboodien G, Engel ME, Syed FF, Poulton J, Badri M, Mayosi BM. The mitochondrial DNA T16189C polymorphism and HIV-associated cardiomyopathy: a genotype-phenotype association study. BMC Med Genet 2009; 10:37.
40. Mayosi BM, Somers K. Cardiomyopathy in Africa: heredity versus environment. Cardiovasc J Afr 2007; 18: 175-179.
41. Skudicky D, Bergemann A, Sliwa K, Candy G, Sareli P. Beneficial effects of pentoxifylline in patients with idiopathic dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitors and carvedilol: results of a randomized study. Circulation 2001; 103: 1083-1088.
42. Sliwa K, Woodiwiss A, Candy G, et al. Effects of pentoxifylline on cytokine profiles and left ventricular performance in patients with decompensated congestive heart failure secondary to idiopathic dilated cardiomyopathy. Am J Cardiol 2002; 90: 1118-1122.
43. Sliwa K, Woodiwiss A, Libhaber E, et al. C-reactive protein predicts response to pentoxifylline in patients with idiopathic dilated cardiomyopathy. Eur J Heart Fail 2004; 6: 731-734.
44. Sliwa K, Forster O, Libhaber E, et al. Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients. Eur Heart J 2006; 27: 441-446.
45. Skudicky D, Sliwa K, Bergemann A, Candy G, Sareli P. Reduction in Fas/APO-1 plasma concentrations correlates with improvement in left ventricular function in patients with idiopathic dilated cardiomyopathy treated with pentoxifylline. Heart (British Cardiac Society) 2000; 84: 438-439.
46. Kawai C. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. Circulation 1999; 99: 1091-1100.
47. Falase AO. Peripartum heart disease. Heart Vessels (Suppl) 1985; 1: 232-235.
48. Sliwa K, Fett J, Elkayam U. Peripartum cardiomyopathy. Lancet 2006; 368: 687-693.
49. Ntusi NB, Mayosi BM. Aetiology and risk factors of peripartum cardiomyopathy: a systematic review. Int J Cardiol 2009; 131: 168-179.
50. Fett JD. Peripartum cardiomyopathy. Insights from Haiti regarding a disease of unknown etiology. Minn Med 2002; 85: 46-48.
51. Sanderson JE, Adesanya CO, Anjorin FI, Parry EH. Postpartum cardiac failure - heart failure due to volume overload? Am Heart J 1979; 97: 613-621.
52. Ford L, Abdullahi A, Anjorin FI, et al. The outcome of peripartum cardiac failure in Zaria, Nigeria. Q J Med 1998; 91: 93-103.
53. Adesanya CO, Anjorin FI, Adeoshun IO, Davidson NM, Parry EH. Peripartum cardiac failure. A ten year follow-up study. Trop Geogr Med 1989; 41: 190-196.
54. Davidson NM, Parry EH. Peri-partum cardiac failure. Q J Med 1978; 47: 431-461.
55. Hilfiker-Kleiner D, Sliwa K, Drexler H. Peripartum cardiomyopathy: recent insights in its pathophysiology. Trends Cardiovasc Med 2008; 18: 173-179.
56. Hilfiker-Kleiner D, Kaminski K, Podewski E, et al. A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell 2007; 128: 589-600.
57. Sliwa K, Blauwet L, Tibazarwa K, et al. Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-ofconcept pilot study. Circulation 2010; 121: 1465-1473.
58. Hu CL, Li YB, Zou YG, et al. Troponin T measurement can predict persistent left ventricular dysfunction in peripartum cardiomyopathy. Heart 2007; 93: 488-490.
59. Caballero-Borrego J, Garcia-Pinilla JM, Rueda-Calle E, de Teresa- Galvan E. [Evidence of gadolinium late-enhancement on cardiac magnetic resonance imaging in a patient with peripartum cardiomyopathy]. Revista espanol Cardiol 2008; 61: 219-220.
60. Kawano H, Tsuneto A, Koide Y, et al. Magnetic resonance imaging in a patient with peripartum cardiomyopathy. Int Med (Tokyo, Japan) 2008; 47: 97-102.
61. Kuhl U, Pauschinger M, Seeberg B, et al. Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation 2005; 112: 1965-1970.
62. Rabausch-Starz I, Schwaiger A, Grunewald K, Muller-Hermelink HK, Neu N. Persistence of virus and viral genome in myocardium after coxsackievirus B3-induced murine myocarditis. Clin Exp Immunol 1994; 96: 69-74.
63. Bultmann BD, Klingel K, Nabauer M, Wallwiener D, Kandolf R. High prevalence of viral genomes and inflammation in peripartum cardiomyopathy. Am J Obstet Gynecol 2005; 193: 363-365.
64. Cenac A, Gaultier Y, Devillechabrolle A, Moulias R. Enterovirus infection in peripartum cardiomyopathy. Lancet 1988; 2: 968-969.
65. O'Connell JB, Costanzo-Nordin MR, Subramanian R, et al. Peripartum cardiomyopathy: clinical, hemodynamic, histologic and prognostic characteristics. J Am Coll Cardiol 1986; 8: 52-56.
66. Midei MG, DeMent SH, Feldman AM, Hutchins GM, Baughman KL. Peripartum myocarditis and cardiomyopathy. Circulation 1990; 81: 922-928.
67. Owor R, Rwomushana RJ. Familial congestive cardiomyopathy in Uganda. East Afr Med J 1975; 52: 372-375.
68. Brink AJ, Torrington M, van der Walt JJ. Hereditary dysrhythmic congestive cardiomyopathy. S Afr Med J 1976; 50: 2119-2123.
69. Przybojewski JZ, van der Walt JJ, van Eeden PJ, Tiedt FA. Familial dilated (congestive) cardiomyopathy. Occurrence in two brothers and an overview of the literature. S Afr Med J 1984; 66: 26-30.
70. Brink AJ, Torrington M. Progressive familial heart block - two types. S Afr Med J 1977; 52: 53-59.
71. Van der Merwe PL, Weymar HW, Torrington M, Brink AJ. Progressive familial heart block. Part II. Clinical and ECG confirmation of progression - report on 4 cases. S Afr Med J 1986; 70: 356-357.
72. Fernandez P, Moolman-Smook J, Brink P, Corfield V. A gene locus for progressive familial heart block type II (PFHBII) maps to chromosome 1q32.2-q32.3. Hum Genet 2005; 118: 133-137.
73. Mayosi BM, Khogali S, Zhang B, Watkins H. Cardiac and skeletal actin gene mutations are not a common cause of dilated cardiomyopathy. J Med Genet 1999; 36: 796-797.
74. Watkins DA, Mayosi BM. The contribution of South Africans to the subject of dilated cardiomyopathy with reference to cardiovascular collagenosis with parietal endocardial thrombosis: a clinicopathologic study of forty cases. Cardiovasc J Afr 2009; 20: 11-16.
75. Higginson J, Gillanders AD, Murray JF. The heart in chronic malnutrition. Br Heart J 1952; 14: 213-24.
76. Svoboda D, Grady H, Higginson J. The effects of chronic protein deficiency in rats. II. Biochemical and ultrastructural changes. Lab Invest 1966; 15: 731-749.
77. Swift PJ. Dietary iron overload as a cause of idiopathic cardiomyopathy in South African blacks: the role of free iron radicals. S Afr Med J 1996; 86: C17-C21.
78. Davies JNP. Endocardial fibrosis in Africans. East Afr Med J 1948; 25:10.
79. William A. Heart disease in the native population of Uganda. East Afr Med J 1938; 15:279.
80. Bukhman G, Ziegler J, Parry E. Endomyocardial fibrosis: still a mystery after 60 years. PLoS Negl Trop Dis 2008; 2: e97.
81. Olsen EG. The role of biopsy in the diagnosis of myocarditis. Herz 1985; 10: 21-26.
82. Freers J, Amandua J, Mugerwa R. Endomyocardial fibrosis and eosinophilia. Lancet 1993; 342:1233.
83. Freers J, Masembe V, Schmauz R, Mayanja-Kizza H. Endomyocardial fibrosis syndrome in Uganda. Lancet 2000; 355: 1994-1995.
84. Freers J, Mayanja-Kizza H, Rutakingirwa M, Gerwing E. Endomyocardial fibrosis: why is there striking ascites with little or no peripheral oedema? Lancet 1996; 347:197.
85. Mocumbi AO, Ferreira MB, Sidi D, Yacoub MH. A population study of endomyocardial fibrosis in a rural area of Mozambique. N Engl J Med 2008; 359: 43-49.
86. Abrahams DG, Barton CJ, Cockshott WP, Edington GM, Weaver EJ. Annular subvalvular left ventricular aneurysms. Q J Med 1962; 31: 345-360.
87. Edington GM, Williams AO. Left atrial aneurysms associated with annular subvalvular left ventricular aneurysms. J Pathol Bacteriol 1968; 96: 273-83.
88. Cockshott WP. Annular subvalvar left ventricular aneurysms. Cardiologia 1968; 52: 109-112.